High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
作者信息
van Dam Peter A, Huizing Manon, Papadimitriou Kostantinos, Prenen Hans, Peeters Marc
机构信息
Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium.
Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium; Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium.
出版信息
Eur J Cancer. 2020 Oct;138:225-227. doi: 10.1016/j.ejca.2020.07.021. Epub 2020 Aug 10.
Abstract
摘要
相似文献
1
High mortality of cancer patients in times of SARS-CoV-2: Do not generalize!
Eur J Cancer. 2020 Oct;138:225-227. doi: 10.1016/j.ejca.2020.07.021. Epub 2020 Aug 10.
2
Re-emergence of SARS-CoV2 in a discharged COVID-19 case.
J Microbiol Immunol Infect. 2020 Jun;53(3):501-502. doi: 10.1016/j.jmii.2020.03.031. Epub 2020 Apr 2.
3
Diagnosis of SARS-CoV-2 infection based on CT scan vs RT-PCR: reflecting on experience from MERS-CoV.
J Hosp Infect. 2020 Jun;105(2):154-155. doi: 10.1016/j.jhin.2020.03.001. Epub 2020 Mar 6.
4
Evaluation of Three Commercial Automated Assays for the Detection of Anti-SARS-CoV-2 Antibodies.
Clin Chem. 2020 Oct 1;66(10):1351-1353. doi: 10.1093/clinchem/hvaa193.
5
SARS-CoV-2 positivity in rectal swabs: implication for possible transmission.
J Glob Antimicrob Resist. 2020 Sep;22:754-755. doi: 10.1016/j.jgar.2020.06.011. Epub 2020 Jul 2.
6
Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives.
Isr Med Assoc J. 2020 Apr;22(4):203-210.
7
What Is the Role of Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Testing in Discontinuation of Transmission-based Precautions for Coronavirus Disease 2019 Patients?
Clin Infect Dis. 2020 Nov 19;71(16):2304-2305. doi: 10.1093/cid/ciaa671.
8
Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR).
Infect Control Hosp Epidemiol. 2020 Nov;41(11):1326-1327. doi: 10.1017/ice.2020.286. Epub 2020 Jun 10.
9
No detection of SARS-CoV-2 in cystic fibrosis patients at the Regional (Lazio) Reference Center for CF in Italy.
J Cyst Fibros. 2020 Sep;19(5):837-838. doi: 10.1016/j.jcf.2020.06.018. Epub 2020 Jun 23.
10
A SINGLE NEGATIVE SARS-COV2 RT-PCR TEST DOES NOT EXCLUDE COVID-19 IN PATIENT WITH SEVERE ARDS, CASE STUDY.
Wiad Lek. 2020;73(8):1800-1803.
引用本文的文献
1
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Front Immunol. 2022 Dec 22;13:1062136. doi: 10.3389/fimmu.2022.1062136. eCollection 2022.
2
Impact of the COVID-19 Pandemic on Delivery of Gynecology and Obstetrics Services at a Maximum Care University Hospital in Germany.
Geburtshilfe Frauenheilkd. 2022 Apr 5;82(4):427-440. doi: 10.1055/a-1687-9674. eCollection 2022 Apr.
3
Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al.
Eur J Cancer. 2020 Nov;139:68-69. doi: 10.1016/j.ejca.2020.08.018. Epub 2020 Sep 6.
本文引用的文献
1
SARS-CoV-2 and cancer: Are they really partners in crime?
Cancer Treat Rev. 2020 Sep;89:102068. doi: 10.1016/j.ctrv.2020.102068. Epub 2020 Jul 11.
2
Factors associated with COVID-19-related death using OpenSAFELY.
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
3
SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
Eur J Cancer. 2020 Aug;135:242-250. doi: 10.1016/j.ejca.2020.06.001. Epub 2020 Jun 6.
4
Determinants of COVID-19 disease severity in patients with cancer.
Nat Med. 2020 Aug;26(8):1218-1223. doi: 10.1038/s41591-020-0979-0. Epub 2020 Jun 24.
5
Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform.
ESMO Open. 2020 Jun;5(3):e000817. doi: 10.1136/esmoopen-2020-000817.
6
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
7
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol. 2020 Jul;21(7):914-922. doi: 10.1016/S1470-2045(20)30314-4. Epub 2020 Jun 12.
Zotero 插件